Patient acceptance of subcutaneous versus transvenous defibrillator systems: A multi‐center experience

The subcutaneous implantable cardioverter‐defibrillator (S‐ICD) is an effective alternative to the transvenous ICD. No study has yet compared S‐ICD and transvenous ICD by assessing patient acceptance as a patient‐centered outcome.

[1]  A. Strömberg,et al.  Psychometric evaluation of the implantable cardioverter defibrillator body image concerns questionnaire (ICD‐BICQ) , 2021, Journal of cardiovascular electrophysiology.

[2]  M. Casula,et al.  Subcutaneous versus Transvenous Implantable Defibrillator: an updated Meta-analysis. , 2020, Heart rhythm.

[3]  P. Lambiase,et al.  Subcutaneous or Transvenous Defibrillator Therapy , 2020, New England Journal of Medicine.

[4]  P. Lambiase,et al.  Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial , 2020, Circulation.

[5]  P. Lambiase,et al.  Quality of life, depression, and anxiety in patients with a subcutaneous versus transvenous defibrillator system , 2019, Pacing and clinical electrophysiology : PACE.

[6]  D. Corrado,et al.  Multicentre experience with the second‐generation subcutaneous implantable cardioverter defibrillator and the intermuscular two‐incision implantation technique , 2019, Journal of cardiovascular electrophysiology.

[7]  R. Kok,et al.  Body image concerns in patients with an implantable cardioverter defibrillator: A scoping review , 2018, Pacing and clinical electrophysiology : PACE.

[8]  A. Moss,et al.  Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT‐RIT substudy , 2017, American heart journal.

[9]  A. Capucci,et al.  The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not? , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  L. Eckardt,et al.  Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems , 2017, Clinical Research in Cardiology.

[11]  S. de Servi,et al.  Submammary device implantation. Good long-term performance and better patients' satisfaction. A single-center experience. , 2016, International journal of cardiology.

[12]  P. Lambiase,et al.  A Comparison of the Quality of Life of Patients With an Entirely Subcutaneous Implantable Defibrillator System Versus a Transvenous System (from the EFFORTLESS S-ICD Quality of Life Substudy). , 2016, The American journal of cardiology.

[13]  P. Bennett,et al.  Living with an implantable cardioverter defibrillator: The patients' experience. , 2016, Heart & lung : the journal of critical care.

[14]  K. Dimopoulos,et al.  Acceptance and psychological impact of implantable defibrillators amongst adults with congenital heart disease. , 2015, International journal of cardiology.

[15]  S. Pedersen,et al.  Gender Differences in Psychological Distress and Quality of Life in Patients with an ICD 1‐Year Postimplant , 2014, Pacing and clinical electrophysiology : PACE.

[16]  C. Semsarian,et al.  Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. , 2013, International journal of cardiology.

[17]  Mark Kremers,et al.  Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator , 2013, Circulation.

[18]  A. Wilde,et al.  Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator. , 2013, Heart rhythm.

[19]  K. Sunagawa,et al.  Gender disparities in quality of life and psychological disturbance in patients with implantable cardioverter-defibrillators. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[20]  M. V. van Assen,et al.  Anxiety and Depression in Patients with an Implantable Cardioverter Defibrillator and Their Partners: A Longitudinal Study , 2013, Pacing and clinical electrophysiology : PACE.

[21]  P. Schauerte,et al.  Depression, psychological distress, and quality of life in patients with cardioverter defibrillator with or without cardiac resynchronization therapy , 2013, Heart and Vessels.

[22]  P. Marshall,et al.  Comparison of male and female psychological outcomes related to implantable cardioverter defibrillators (COMFORTID) , 2012, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[23]  L. Jordaens,et al.  Gender disparities in anxiety and quality of life in patients with an implantable cardioverter-defibrillator. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[24]  S. Pedersen,et al.  Patient-reported outcomes in Danish implantable cardioverter defibrillator patients with a Sprint Fidelis lead advisory notification. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[25]  J. Denollet,et al.  Gender Disparities in Psychological Distress and Quality of Life among Patients with an Implantable Cardioverter Defibrillator , 2011, Pacing and clinical electrophysiology : PACE.

[26]  M. Giudici,et al.  Submammary Pacemakers and ICDs in Women: Long‐Term Follow‐up and Patient Satisfaction , 2010, Pacing and clinical electrophysiology : PACE.

[27]  S. Pedersen,et al.  Gender Differences in Anxiety and Concerns about the Cardioverter Defibrillator , 2009, Pacing and clinical electrophysiology : PACE.

[28]  M. Burg,et al.  Does ICD Indication Affect Quality of Life and Levels of Distress? , 2009, Pacing and clinical electrophysiology : PACE.

[29]  Emily A. Kuhl,et al.  Age‐Specific Differences in Women with Implantable Cardioverter Defibrillators: An International Multi Center Study , 2008, Pacing and clinical electrophysiology : PACE.

[30]  J. Shea,et al.  Quality of Life Among Implantable Cardioverter‐Defibrillator Recipients in the Primary Prevention Therapeutic Era , 2007, Pacing and clinical electrophysiology : PACE.

[31]  Emily A. Kuhl,et al.  Device implant technique and consideration of body image: specific procedures for implantable cardioverter defibrillators in female patients. , 2006, Journal of women's health.

[32]  Erika Friedmann,et al.  Quality of life and psychological status of patients with implantable cardioverter defibrillators. , 2006, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[33]  D. Carroll,et al.  Quality of life in implanted cardioverter defibrillator recipients: the impact of a device shock. , 2005, Heart & lung : the journal of critical care.

[34]  S. Sears,et al.  Measuring Patient Acceptance of Implantable Cardiac Device Therapy: , 2005, Journal of cardiovascular electrophysiology.

[35]  Beth A. Glenn,et al.  Women and the implantable cardioverter defibrillator: A lifespan perspective on key psychosocial issues , 2004, Clinical cardiology.

[36]  R. Hauer,et al.  Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. , 2003, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.